MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression
Authors:
- 1 April 2016
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 79, 315-320
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizonsEuropean Journal of Cancer, 2015
- MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approachesCell Death & Differentiation, 2014
- NF-κB, an Active Player in Human CancersCancer Immunology Research, 2014
- miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinomaOncogene, 2014
- Role of 3’-untranslated region translational control in cancer development, diagnostics and treatmentWorld Journal of Biological Chemistry, 2014
- MicroRNA-26a Suppresses Angiogenesis in Human Hepatocellular Carcinoma by Targeting Hepatocyte Growth Factor-cMet PathwayHepatology, 2013
- Ebola virus VP35 induces high-level production of recombinant TPL-2–ABIN-2–NF-κB1 p105 complex in co-transfected HEK-293 cellsBiochemical Journal, 2013
- Intermediate hepatocellular carcinoma: current treatments and future perspectivesAnnals of Oncology, 2013
- β2 integrins inhibit TLR responses by regulating NF‐κB pathway and p38 MAPK activationEuropean Journal of Immunology, 2013
- ABINs: A20 binding inhibitors of NF-κB and apoptosis signalingBiochemical Pharmacology, 2009